| About | Exhibitors | 23 Speakers | Reviews | Deals |
Excited about the event? Spread the word and invite your network!
Share
The Annual T-Cell Engager Therapeutics Summit is a premier conference focusing on the rapidly advancing field of T-cell engagers (TCEs) and immune cell engagers. This year’s summit is set to delve into the translation of TCEs from discovery to clinical application and regulatory approval, reflecting a significant growth in this
...
area with eight recent approvals, including the noteworthy tarlatamab. The summit will bring together a diverse group of industry leaders, including C-suite executives, biotech professionals, and pharma experts, all committed to shaping the future of immuno-oncology.
The program will feature discussions on innovative strategies to enhance efficacy and safety in treating solid tumors, while also exploring new opportunities in autoimmune diseases. Attendees will gain critical insights into overcoming ongoing challenges such as identifying novel tumor targets, improving treatment durability, minimizing on-target, off-tumor toxicity, and optimizing dosing for first-in-human studies. The summit will include presentations from renowned speakers, including a Senior Vice President of Clinical Development and an Executive Director in charge of Immune Engagers, who will share their expertise and insights into the latest breakthroughs driving immune therapy innovations. The intimate setting of the conference fosters rich networking opportunities, allowing participants to engage directly with thought leaders and peers in the field. Feedback from previous attendees highlights the focused nature of the discussions and the value of the workshops, which encourage open dialogue and interaction. The Annual T-Cell Engager Therapeutics Summit promises to be an essential gathering for anyone involved in the development and application of T-cell engagers, offering a platform for learning, sharing ideas, and advancing professional connections in this dynamic area of research.
The program will feature discussions on innovative strategies to enhance efficacy and safety in treating solid tumors, while also exploring new opportunities in autoimmune diseases. Attendees will gain critical insights into overcoming ongoing challenges such as identifying novel tumor targets, improving treatment durability, minimizing on-target, off-tumor toxicity, and optimizing dosing for first-in-human studies. The summit will include presentations from renowned speakers, including a Senior Vice President of Clinical Development and an Executive Director in charge of Immune Engagers, who will share their expertise and insights into the latest breakthroughs driving immune therapy innovations. The intimate setting of the conference fosters rich networking opportunities, allowing participants to engage directly with thought leaders and peers in the field. Feedback from previous attendees highlights the focused nature of the discussions and the value of the workshops, which encourage open dialogue and interaction. The Annual T-Cell Engager Therapeutics Summit promises to be an essential gathering for anyone involved in the development and application of T-cell engagers, offering a platform for learning, sharing ideas, and advancing professional connections in this dynamic area of research.
Listed In
Excited about the event? Spread the word and invite your network!
Share
Timings08:00 AM - 04:30 PM (General)
09:00 AM - 03:30 PM (General)
| Entry FeesCheck Official Website |
Estimated Turnout0-300 Delegates Based on previous editions | Event TypeConference |
EditionsJun 2025, Boston InterestedJun 2021, Online +4 more editions Frequency Annual | Official LinksWebsiteContacts Report Error Claim this event |
Organizer Queries about the event?
Ask Organizer
| |
42.361416-71.066598 Venue Map & Directions | |
Near the venue with time to spare? New in town?
Invite others for coffee and plan your day!
Frequently Asked Questions Contact Organizer
Can I get a list of speakers participating in the event?
Can I get a list of exhibitors participating in the event?
Ask More Questions
Write a Review
Add Your Review EditionJun 2025
How would you like to participate in this event?
Visitor
Exhibitor
Speaker
Followers [ Users who have shown interest for this Event ] Join Community Invite
Add Profile
Invite users with similar interest
Frida Hedman
Properiter
Boston, United States
Leonard Rodman
Medical Student
Boston, United States
Varun
Boston, United States
Kim Hennigar
Branding, Custom Apparel and P
Boston, United States
Scott Burroughs
HVAC
Boston, United States
Mike Endrusick
Operations
Boston, United States
Dan Tucci
Founder
Boston, United States
Jilma Sweeney
President
Boston, United StatesView More
Speakers
Speaker
Lauren Harshman
Senior Vice PresidentSpeaker
Milos Aleksic
Senior Director - Drug DiscoverySpeaker
Milton To
Senior ScientistSpeaker
Mithun Khattar
Director - Immuno-Oncology ResearchSpeaker
Nina Weisser
Director - Multispecific Antibody TherapeuticsSpeaker
Oksana Sergeeva
Principal Scientist - Translational Science42.361416-71.066598
Venue Map & Directions
5 Blossom St, Boston, MA 02114
USA
More Events in Boston
 Apr 292025 | Annual GLP - 1 Based Therapeutics Summit Boston, USA |
| Apr 302025 | Cochlear Implants in Children and Adults Boston, USA |
| Aug 182025 | The Bioprocessing Summit Boston, USA |
| Sep 102025 | Decarb Connect North America Boston, USA |
| Oct 032025 | The Clinical Pathways Congress + Cancer Care Business Exchange Boston, USA |
Sponsors
Alloy Therapeutics
Expertise Partnerhttps://10times.com/hub/medical-pharma-hub
May 192025
